Table 3.
After ICU admission | |||
---|---|---|---|
Day 1 | Day 3 | Day 7 | |
Hemoglobin (g/L) | |||
Survivor | 125 (103–163) | 106 (90–180) | 95 (81–160) |
Non-survivor | 123 (100–161) | 99 (78–155) | 95 (80–112) |
RDW (%) | |||
Survivor | 13.3 (11.5–19.0) | 14.0 (11.9–19.8) | 13.9 (11.9–18.7) |
Non-survivor | 14.2 (11.8–19.9) | 15.4 (12.2–20.1)a | 15.3 (12.5–20.4)a |
EPO (IU/L) | |||
Survivor | 93.8 (49.6–428.4) | 44.7 (20.0–278.7)b | 20.7 (10.9–130.5)b |
Non-survivor | 51.3 (20.8–126.2)a | 23.1 (12.1–81.4)ab | 11.1 (8.1–29.4)ab |
sTfR (nmol/L) | |||
Survivor | 20.2 (13.5–27.9) | 20.4 (13.5–27.8) | 21.7 (13.7–27.9) |
Non-survivor | 20.7 (13.4–28.0) | 20.5 (13.6–28.1) | 19.6 (13.4–27.4) |
Hepcidin (ng/mL) | |||
Survivor | 133.9 (60.2–185.5) | 66.3 (24.8–95.3)b | 45.7 (20.4–69.3)b |
Non-survivor | 172.2 (110.1–231.5)a | 99.8 (45.9–122.4)ab | 65.6 (35.2–99.7)ab |
Iron (µmol/L) | |||
Survivor | 8.1 (2.3–12.5) | 8.6 (2.4–15.4) | 10.6 (3.3–19.4) |
Non-survivor | 7.6 (2.3–15.7) | 6.3 (2.9–8.2)a | 6.6 (3.0–11.4)a |
Ferritin (ng/mL) | |||
Survivor | 172.5 (85.2–237.1) | 555.0 (340.1–615.8)b | 276.7 (99.5–524.6)b |
Non-survivor | 227.1 (110.7–302.8)a | 581.9 (423.9–702.4)ab | 322.5 (218.6–364.6)a |
IL–6 (pg/mL) | |||
Survivor | 34.2 (15.7–55.5) | 23.3 (8.6–45.3)b | 21.9 (11.7–89.0)b |
Non-survivor | 124.3 (49.3–171.9)a | 76.0 (29.0–153.6)ab | 44.9 (10.2–107.2)ab |
sTfR/log ferritin | |||
Survivor | 9.0 (6.1–12.5) | 7.5 (4.9–10.4) | 9.3 (5.5–13.2) |
Non-survivor | 8.8 (5.7–11.9) | 6.3 (4.9–10.3)a | 7.9 (5.4–11.0)a |
Creatinine (µmol/L) | |||
Survivor | 119 (56–188) | 132 (114–201) | 124 (67–196) |
Non-survivor | 138 (65–198)a | 176 (114–235)ab | 217 (115–311)ab |
Values are the mean ± standard deviation or median (range)
EPO erythropoietin; IL-6 interleukin-6; RDW red blood cell distribution width; sTfR soluble transferrin receptor
aP < 0.05 vs. survivor
bP < 0.05 vs. day 1 of ICU admission